StockSelector.com
  Research, Select, & Monitor Friday, September 25, 2020 12:31:26 AM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Gilead Sciences, Inc.$62.25($.84)(1.33%)

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

Gilead Sciences, Inc. has an overall rank of 2134 out of 7709 stocks based on 11 positive rankings and 11 negative rankings.

Positive Rankings
Top Industry Values
Gilead Sciences rank is 52
Highest Net Margin
Gilead Sciences rank is 308
Highest ROE
Gilead Sciences rank is 498
Target Prices
The average analysts' target price is $80.29 for Gilead Sciences using target prices set or adjusted within the past 90 days. Among companies with recent target prices and with the average above the current stock price, Gilead Sciences is ranked 637.
Highest ROA
Gilead Sciences rank is 645
Up Estimate Revision
During the past month, the consensus earnings estimate for the current year and next year have increased by a combined 0.14%. Among companies that have had their estimates raised within the past month, Gilead Sciences is ranked 653.
Estimated EPS Growth
Gilead Sciences rank is 977
Estimated Revenue Growth
Gilead Sciences rank is 1005
Oversold Stochastics
Gilead Sciences rank is 1022
Highest Cash Growth
Gilead Sciences rank is 1408
Low Put/Call
Gilead Sciences has a low Put/Call ratio of 0.54 on all open interest of options expiring in the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, Gilead Sciences is ranked 1709.
Negative Rankings
Missed Whisper
According to EarningsWhispers.com, Gilead Sciences missed the Earnings Whisper number when it last reported earnings. Statistics show that companies that have missed the Earnings Whisper number underperform the market in the short-term.
Negative MACD Cross
The MACD Divergence has recently become negative while the MACD remains positive. This is typically a negative short-term indicator.
Down EPS Surprise
Gilead Sciences missed the consensus earnings estimate when it last reported quarterly earnings.
90 Day Loss
Gilead Sciences rank is 830
Negative Past Growth
Gilead Sciences rank is 892
Negative Revenue Growth
Gilead Sciences rank is 979
Price-to-Book
Gilead Sciences rank is 1402
Price-to-Sales
Gilead Sciences rank is 1475
Debt-to-Equity
Gilead Sciences rank is 2041
High vPut/Call
Gilead Sciences has a high Put/Call ratio of 0.47 on active options expiring within the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, Gilead Sciences is ranked 2252.
10 Day Loss
Gilead Sciences rank is 2981







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2020 StockSelector.com. All rights reserved.